Local recurrence and local control of non-metastatic osteosarcoma of the extremities: A 27-year experience in a single institution

被引:109
作者
Bacci, Gaetano
Forni, Cristiana
Longhi, Alessandra
Ferrari, Stefano
Mercuri, Mario
Bertoni, Franco
Serra, Massimo
Briccoli, Antonio
Balladelli, Alba
Picci, Piero
机构
[1] Istituto Ortopedico Rizzoli, Sezione Chemioterapio, I-40136 Bologna, Italy
[2] Inst Ortoped Rizzoli, Dept Musculoskeletal Oncol, Bologna, Italy
[3] Inst Ortoped Rizzoli, Dept Musculoskeletal Oncol, Lab Oncol Res, Bologna, Italy
关键词
local recurrence; osteosarcoma; local control;
D O I
10.1002/jso.20628
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Indications and contraindications for limb salvage versus amputation for local treatment of osteosarcoma of the extremity are still controversial. Patients and Methods: Patients (1,126) with non-metastatic osteosarcoma of the extremity, treated in a single institution between 1972 and 1999 with different protocols of adjuvant and neoadjuvant chemotherapy were evaluated to establish factors that could influence local recurrence (LR) and outcome. Results: The 5-year event-free survival and overall survival were 55% and 66%. At a follow-up ranging between 5.5 and 32.5 years (mean 18.6 years) of the 1,126 evaluated patients, 607 (54%) remained continuously disease-free and 519 relapsed. LR developed in 61 patients (5.4%) after a median time of 2.3 years (0.2-17). For this group of patients the 5-year post-relapse event-free survival and overall survival from the last relapse were, respectively, 11.4% and 16.4%. At the multivariate analyses only surgical margins and histologic response to preoperative treatment resulted to be independent prognostic factors for LR. Conclusion: Considering the risk of LR after surgery with inadequate surgical margins and poor prognosis of LR in osteosarcoma, limb salvage procedures should be performed only when adequate margins surgical margins can be achieved. In case of inadequate margins, an immediate amputation should be considered.
引用
收藏
页码:118 / 123
页数:6
相关论文
共 28 条
[1]   Osteosarcoma of the limb - Amputation or limb salvage in patients treated by neoadjuvant chemotherapy [J].
Bacci, G ;
Ferrari, S ;
Lari, S ;
Mercuri, M ;
Donati, D ;
Longhi, A ;
Forni, C ;
Bertoni, R ;
Versari, M ;
Pignotti, E .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2002, 84B :88-92
[2]   Predictive factors for local recurrence in osteosarcoma - 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy [J].
Bacci, G ;
Ferrari, S ;
Mercuri, M ;
Bertoni, F ;
Picci, P ;
Manfrini, M ;
Gasbarrini, A ;
Forni, C ;
Cesari, M ;
Campanacci, M .
ACTA ORTHOPAEDICA SCANDINAVICA, 1998, 69 (03) :230-236
[3]  
BACCI G, 1993, CANCER, V72, P3227, DOI 10.1002/1097-0142(19931201)72:11<3227::AID-CNCR2820721116>3.0.CO
[4]  
2-C
[5]   High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: Preliminary results of an Italian sarcoma group/Scandinavian sarcoma group pilot study [J].
Bacci, G ;
Ferrari, S ;
Longhi, A ;
Picci, P ;
Mercuri, M ;
Alvegard, TA ;
Saeter, G ;
Donati, D ;
Manfrini, M ;
Lari, S ;
Briccoli, A ;
Forni, C .
JOURNAL OF CHEMOTHERAPY, 2002, 14 (02) :198-206
[6]  
BACCI G, 1990, CANCER, V65, P2539, DOI 10.1002/1097-0142(19900601)65:11<2539::AID-CNCR2820651125>3.0.CO
[7]  
2-M
[8]   ADRIAMYCIN METHOTREXATE HIGH-DOSE VERSUS ADRIAMYCIN METHOTREXATE MODERATE DOSE AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA OF THE EXTREMITIES - A RANDOMIZED STUDY [J].
BACCI, G ;
GHERLINZONI, F ;
PICCI, P ;
VANHORN, JR ;
JAFFE, N ;
GUERRA, A ;
RUGGIERI, P ;
BIAGINI, R ;
CAPANNA, R ;
TONI, A ;
MERCURI, M ;
DALLARI, D ;
CAMPANACCI, M .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (11) :1337-1345
[9]   Osteosarcoma: Relationship of response to preoperative chemotherapy and type of surgery to local recurrence [J].
Bielack, SS ;
KempfBielack, B ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :683-684
[10]   Surgical procedure and local recurrence in 223 patients treated 1982-1997 according to two osteosarcoma chemotherapy protocols -: The Scandinavian Sarcoma Group experience [J].
Brosjö, O .
ACTA ORTHOPAEDICA SCANDINAVICA, 1999, 70 :58-61